Royal Stoke University Hospital is a teaching and research hospital at Hartshill in the English county of Staffordshire. It lies in the city of Stoke-on-Trent, near the border with Newcastle-under-Lyme, and is one of the largest hospitals in the country and a major local employer, with over 6,000 staff.

There are 1,328 beds in University Hospitals of North Midlands NHS Trust.

During the past decade, University Hospitals of North Midlands NHS Trust conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 11 clinical trials were completed, i.e. on average, 24.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 9 clinical trials were completed. i.e. 64.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospitals of North Midlands NHS Trust" #1 sponsor was "University Hospitals of North Midlands NHS Trust" with 12 trials, followed by "Allergan" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Intec Pharma Ltd." with 2 trials sponsored and "Queen Mary University of London" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospitals of North Midlands NHS Trust" #1 collaborator was "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Barts & The London NHS Trust" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "University Hospitals of North Midlands NHS Trust" are "Gastroparesis" (3 trials), "Breast Cancer" (2 trials), "Covid19" (2 trials), "Cystic Fibrosis" (2 trials) and "Diabetes Mellitus" (2 trials). Many other conditions were trialed in "University Hospitals of North Midlands NHS Trust" in a lesser frequency.

Most popular intervention types in "University Hospitals of North Midlands NHS Trust" are "Drug" (22 trials), "Other" (10 trials), "Device" (6 trials), "Diagnostic Test" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Atezolizumab" (2 trials), "Blood samples" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospitals of North Midlands NHS Trust" are 41 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospitals of North Midlands NHS Trust". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in University Hospitals of North Midlands NHS Trust, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospitals of North Midlands NHS Trust, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".

University Hospitals of North Midlands NHS Trust has several departments that took part in Clinical trials: "Uni Hospital of North Staffordshire; Staffordshire Oncology Centre" - 3 trials